EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme
pharmaphorum
NOVEMBER 27, 2020
The deal was agreed well before Teva bought Cephalon in 2011 for $6.8 The two companies agreed to settle the dispute but as part of the settlement Teva received a package of commercial side-deals and cash payments. billion and involved a complex series of transactions instead of an up-front payment.
Let's personalize your content